accunome
Jiaxing
About accunome
accunome is the generation molecular diagnostic platform DXcellence12 has received the state food and drug registration certificate as the EU CE certification, and the combined detection kit for influenza A/B and respiratory syncytial virus nucleic acid has the EU CE certification.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Funding stage: Private Equity
- Last round: Private Equity (Dec 2022)
- Website: accunome.com.cn
- Phone: +86 0573-82060718
Industries & Categories
Biotechnology, Manufacturing, Medical, Medical Device
Canonical: https://fsome.com/organization/accunome-2942387 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.